Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWViolacein is a bacterial metabolite originally isolated from C. violaceum that has antibacterial and antiprotozoal activities.1,2 It is produced by C. violaceum as a purple pigment in response to N-hexanoyl homoserine lactone (Item No. 10007896), a property that has been modified to create a strain of C. violaceum used in detecting quorum-sensing molecules.3 Violacein is active against Gram-positive bacteria, including B. subtilis and S. aureus (MICs = 0.8 and 1.6 µM, respectively). It is also active against P. falciparum, including chloroquine-susceptible and -resistant strains (IC50s = 0.85 and 0.63 µM, respectively).2 It reduces parasitemia in a mouse model of nonlethal P. chabaudi chabaudi infection when administered at a dose of 7.5 mg/kg and increases survival in a mouse model of lethal P. chabaudi chabaudi infection. Violacein permeabilizes the cytoplasmic membrane of bacterial cells but does not affect the cell wall.1
WARNING This product is not for human or veterinary use.
1. Violacein targets the cytoplasmic membrane of bacteria. ACS Infect. Dis. 5(4), 539-549 (2019).
2. Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo. Antimicrob. Agents Chemother. 53(5), 2149-2152 (2009).
3. Extraction of violacein from Chromobacterium violaceum provides a new quantitative bioassay for N-